Citius Pharmaceuticals Inc (CTXR)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
9
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ 07016
(908) 967-6676

Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for growing markets. Citius products offer new and expanded indications for previously-approved pharmaceutical products as a means to achieve leading market positioning.

Data derived from most recent annual or quarterly report
Market Cap 210.283 Million Shares Outstanding146.03 Million Avg 30-day Volume 1.415 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.24
Price to Revenue0.0 Debt to Equity0.01 EBITDA-17.448 Million
Price to Book Value1.2097 Operating Margin0.0 Enterprise Value27.21 Million
Current Ratio3.413 EPS Growth0.416 Quick Ratio3.383
1 Yr BETA 1.0714 52-week High/Low 4.56 / 1.15 Profit Margin0.0
Operating Cash Flow Growth-36.1231 Altman Z-Score-0.8947 Free Cash Flow to Firm -13.13 Million
View SEC Filings from CTXR instead.

View recent insider trading info

Funds Holding CTXR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTXR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOLUBIAK MYRON Z PRESIDENT AND CEO

  • Officer
  • Director
5,031,271 2021-10-11 2

SAFIR HOWARD

  • Director
225,405 2021-10-11 3

MAZUR LEONARD L EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
19,683,803 2021-10-11 2

DUTIA SUREN G

  • Director
226,667 2021-10-11 3

WEBB CAROL

  • Director
225,405 2021-10-11 3

KANE WILLIAM

  • Director
225,405 2021-10-11 3

HOLUKA EUGENE MYRON

  • Director
215,749 2021-10-11 3

BARTUSHAK JAIME CHIEF FINANCIAL OFFICER

  • Officer
828,620 2021-10-11 2

CZUCZMAN MYRON CHIEF MEDICAL OFFICER

  • Officer
800,000 2021-10-11 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 22:15:03 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 21:45:03 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 21:15:04 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 20:45:03 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 20:15:04 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 19:45:03 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 19:15:03 UTC -1.763 1.833 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 18:45:03 UTC -1.7658 1.8358 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 18:15:03 UTC -1.7658 1.8358 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 17:45:03 UTC -1.7658 1.8358 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 17:15:03 UTC -1.7658 1.8358 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 16:45:04 UTC -1.7704 1.8404 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 16:15:03 UTC -1.7704 1.8404 500000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 15:45:03 UTC -1.7704 1.8404 550000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 15:15:03 UTC -1.7704 1.8404 550000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 14:45:04 UTC -1.7704 1.8404 550000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 14:15:03 UTC -1.7704 1.8404 550000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 13:45:03 UTC -2.0778 2.1478 550000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 13:15:03 UTC -2.0778 2.1478 550000
CITIUS PHARMACEUTICALS INC CTXR 2022-01-25 12:45:03 UTC -2.0778 2.1478 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments